BAY-293
CAS No. 2244904-70-7
BAY-293( BAY293 | BAY 293 )
Catalog No. M13599 CAS No. 2244904-70-7
BAY-293 (BAY293, BAY 293) is a potent, cell-active SOS1 inhibitor that disrupts the KRAS-SOS1 interaction with IC50 of 21 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 102 | In Stock |
|
| 10MG | 177 | In Stock |
|
| 25MG | 356 | In Stock |
|
| 50MG | 530 | In Stock |
|
| 100MG | 759 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBAY-293
-
NoteResearch use only, not for human use.
-
Brief DescriptionBAY-293 (BAY293, BAY 293) is a potent, cell-active SOS1 inhibitor that disrupts the KRAS-SOS1 interaction with IC50 of 21 nM.
-
DescriptionBAY-293 (BAY293, BAY 293) is a potent, cell-active SOS1 inhibitor that disrupts the KRAS-SOS1 interaction with IC50 of 21 nM; displays no significant activity against KRAS WT-CRAF RBD, CDC42 and EGFR (>20 uM); blocks reloading of KRAS with GTP, does not stabilize KRASWT or KRASG12C; inhibits the activation of RAS in HeLa cells with IC50 of 410 nM, efficiently inhibits pERK levels in K562 cells after incubation for 60 min without affecting total protein levels of ERK (IC50=180 nM); shows antiproliferative activity against wild-type KRAS cell lines (K562, MOLM-13; IC50~1 uM) and cell lines with KRASG12C mutation (NCI-H358, Calu-; IC50~3 uM) by preventing formation of the KRAS-SOS1 complex, also shows synergic antiproliferative effect with covalent KRASG12C inhibitor ARS-853; BAY-293 is a valuable chemical probe for investigation of the activation of KRAS by SOS1.
-
In VitroBAY-293 inhibits the activation of RAS in HeLa cells, with IC50 values in the submicromolar range. BAY-293 (595 nM-3580 nM; 72 hours) shows efficient antiproliferative activity against wild-type KRAS cell lines (K-562, MOLM-13) and cell lines with KRASG12C mutation (NCI-H358, Calu-1). BAY-293 efficiently inhibits pERK levels in K-562 cells after incubation for 60 min without affecting total protein levels of ERK. Cell Proliferation AssayCell Line:K-562, MOLM-13, H358 and Calu-1 cell linesConcentration:595-3580 nMIncubation Time:72 hoursResult:IC50s of 1,090±170 nM, 995±400 nM, 3,480±100 nM and 3,190±50 nM for K-562, MOLM-13, H358 and Calu-1 cells, respectively.
-
In Vivo——
-
SynonymsBAY293 | BAY 293
-
PathwayMAPK/ERK Signaling
-
TargetRas
-
RecptorKRAS-SOS1interaction
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2244904-70-7
-
Formula Weight448.585
-
Molecular FormulaC25H28N4O2S
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 125 mg/mL 278.66 mM
-
SMILESC[C@@H](NC1=C2C=C(OC)C(OC)=CC2=NC(C)=N1)C3=CC(C4=CC=CC=C4CNC)=CS3
-
Chemical Name(R)-6,7-dimethoxy-2-methyl-N-(1-(4-(2-((methylamino)methyl)phenyl)thiophen-2-yl)ethyl)quinazolin-4-amine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Hillig RC, et al. Proc Natl Acad Sci U S A. 2019 Jan 25. pii: 201812963. doi: 10.1073/pnas.1812963116.
molnova catalog
related products
-
K-Ras G12C-IN-12
An allosteric inhibitor of oncogenic K-Ras(G12C) with EC50 of 0.32 uM in H1792 cells.
-
UC-773587
A small molecule inhibitor of guanine nucleotide exchange factor (GEF) catalytic activity that binds to SOS1 (Kd=3.4 uM) and disrupts GEF-Ras interaction.
-
K-Ras G12C-IN-2
A novel and irreversible inhibitor of mutant K-ras G12C.
Cart
sales@molnova.com